US2005163863A1PendingUtilityA1

Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans

37
Assignee: CENTRE NAT RECH SCIENTPriority: Apr 26, 2002Filed: Apr 25, 2003Published: Jul 28, 2005
Est. expiryApr 26, 2022(expired)· nominal 20-yr term from priority
Inventors:Kmar Chelbi AlixPedro Bobe
A61P 37/00A61P 3/10A61P 19/00A61P 17/00A61K 33/36
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of an arsenic compound for the preparation of a medicament that is used to treat autoimmune diseases.

Claims

exact text as granted — not AI-modified
1 . The use of an arsenic compound for preparing a medical product for treating autoimmune diseases.  
     
     
         2 - 20 . (canceled)

Join the waitlist — get patent alerts

Track US2005163863A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.